HIV CURE SYMPOSIUM

11-12 September
Ghent, Belgium

Program


The program offers multiple perspectives on the HIV cure field, showcasing exciting recent research findings with potential for clinical translation. 

The conference sessions will present the latest research and foster discussion on:

• The establishment of the HIV reservoir

• The adaptive and innate immune responses associated with HIV control

• The molecular characteristics of the viral reservoirs 

• The development of new therapies


MONDAY 11 SEPTEMBER
12.30-13.00Registration
13.00-13.10Welcome and Introduction
13.10-14.45HIV CURE: PHENOTYPES AND RELATED QUESTIONS THAT SHOULD HELP US MOVING FORWARD
13.10-13.35HIV care versus cure in Europe anno 2023: mapping the impact of the Ukraine war
Milosz Parczewski, Pomeranian Medical University, Szczecin, Poland
13.35-14.00The reservoir establishment
Zabrina Brumme, Simon Fraser University, Burnaby, Canada
14.00-14.25HIV silencing and cell survival signatures in infected T cell reservoirs
Eli Boritz, NIH Main Campus, Bethesda, United States
14.25-14.35Abstract Presentation
14.35-14.45Abstract Presentation
14.45-15.05Break
15.05-16.15HIV RESERVOIR PERSISTENCE CONTRIBUTING TO VIREMIA
15.05-15.30Proviruses in self-reactive cd4+ t cells are a common source of residual HIV viremia
Francesco Simonetti, Johns Hopkins University, Maryland, Unites States
15.30-15.55Viral and host mediators of persistent low-level viremia
Jonathan Li, Harvard University, Cambridge, United States
15.55-16.05Abstract Presentation
16.05-16.15Abstract Presentation
16.15-16.35Break
16.35-18.10HIV RESERVOIR PHENOTYPE
16.35-17.00T-trace enables single-cell multi-omics analysis of HIV reservoir cells
Nadia Roan, gladstone Institutes, California, United States
17.00-17.25Single-cell profiling of leaky latent hiv-1 reservoirs in art-treated donors
Daniel Kaufmann, University of Lausanne, Lausanne, Switzerland
17.25-17.50Cellular characteristics of the viral reservoir
Speaker tbc
17.50-18.00Abstract Presentation
18.00-18.10Abstract Presentation
18.10-19.30NETWORK RECEPTION
TUESDAY 12 SEPTEMBER 2023
09.00-09.30Registration
09.30-10.40TRAINED IMMUNITY AND HIV CONTROL SESSION 1
09.30-09.55Learning to Be Elite: Lessons From HIV-1 Controllers and Animal Models on Trained Innate Immunity and Virus Suppression
Speaker tbc
09.55-10.20Monocytes of hiv-1 elite controllers and relatives show enhanced trained immunity
Jessica dos Santos, Radboud University, The Netherlands
10.20-10.30Abstract Presentation
10.30-10.40Abstract Presentation
10.40-11.50NK CELL IMMUNITY AND HIV CONTROL SESSION 2
10.40-11.05Distinct NK cell responses define durable control in elite controllers
Speaker tbc
11.05-11.30Engaging innate immunity in HIV-1 cure strategies
Speaker tbc
11.30-11.40Abstract Presentation
11.40-11.50Abstract Presentation
11.50-13.30Lunch
13.30-14.40TISSUE AND TR CELLS
13.30-13.55Characterization of tissue-resident nk cells in a tissue model of hiv infection
Speaker tbc
13.55-14.20An in situ analysis pipeline for initial host-pathogen interactions reveals signatures of human colorectal HIV transmission
Speaker tbc
14.20-14.30Abstract Presentation
14.30-14.40Abstract Presentation
14.40-15.20Poster session + break
15.20-17.00CORRELATES OF HIV CONTROL
15.20-15.45HIV control in antibody trials
Martin Tolstrup, Aarhus University, Denmark
15.45-16.10SIV control
Ashish Sharma, Emory University, Atlanta, United States
16.10-16.20Abstract Presentation
16.20-16.30Abstract Presentation
16.30-16.55Conclusion and Future directions for cure
Rafick-Pierre Sekaly, Emory University, Atlanta, United States
16.55-17.00Closing remarks

WERELDWIJD LEVEN 37 MILJOEN MENSEN MET HIV. STEUN HET FONDS HIV ONTRAFELEN en Help hen.

Doe een online gift

qrcode_actieplatform.ugent.be